Hereditary Transthyretin Mediated Amyloidosis With Polyneuropathy clinical trials

Explore recruiting hereditary transthyretin mediated amyloidosis with polyneuropathy clinical trials.

Recruiting hereditary transthyretin mediated amyloidosis with polyneuropathy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hereditary Transthyretin Mediated Amyloidosis With Polyneuropathy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

TRITON-PN: A Phase 3, Global, Randomized, Open-Label Study to Evaluate the Efficacy and Safety of Nucresiran in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy (hATTR-PN)

France, Italy, Greece, Spain, Sweden, Ireland +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Hereditary Transthyretin Mediated Amyloidosis With Polyneuropathy trials by city

Hereditary Transthyretin Mediated Amyloidosis With Polyneuropathy in Toronto Hereditary Transthyretin Mediated Amyloidosis With Polyneuropathy in Vancouver Hereditary Transthyretin Mediated Amyloidosis With Polyneuropathy in Montreal Hereditary Transthyretin Mediated Amyloidosis With Polyneuropathy in Calgary Hereditary Transthyretin Mediated Amyloidosis With Polyneuropathy in Edmonton Hereditary Transthyretin Mediated Amyloidosis With Polyneuropathy in Ottawa Hereditary Transthyretin Mediated Amyloidosis With Polyneuropathy in Winnipeg Hereditary Transthyretin Mediated Amyloidosis With Polyneuropathy in Quebec City Hereditary Transthyretin Mediated Amyloidosis With Polyneuropathy in Hamilton Hereditary Transthyretin Mediated Amyloidosis With Polyneuropathy in Kitchener Hereditary Transthyretin Mediated Amyloidosis With Polyneuropathy in London Hereditary Transthyretin Mediated Amyloidosis With Polyneuropathy in Halifax Hereditary Transthyretin Mediated Amyloidosis With Polyneuropathy in New York Hereditary Transthyretin Mediated Amyloidosis With Polyneuropathy in Los Angeles Hereditary Transthyretin Mediated Amyloidosis With Polyneuropathy in Chicago Hereditary Transthyretin Mediated Amyloidosis With Polyneuropathy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease